Viridian Therapeutics, Inc.\DE

Viridian Therapeutics: Two Products, One Commercial Buildout

Viridian Therapeutics is building a shared commercial platform for Lumvoa and investigational elegrobart in thyroid eye disease, with…

VRDN $2.8B

SA Equity Eagle Sep 17